F2g Ltd

#03578625 Active

F2G is dedicated to transforming the treatment of rare, invasive fungal infections by developing innovative antifungal therapies. Their commitment to patient care drives their research and development efforts.

Founded: 10 Jun 1998
Industries:
72110 - Research and experimental development on biotechnology
Website: f2g.com
Location: Macclesfield

Products & Services

• antifungal
• antifungal medications for rare fungal infections
• biotechnology
• biotechnology
• development of novel antifungal therapies
• fungal infections
• genetics
• healthcare
• health care
• medical
• novel therapies
• pharmaceutical

Financial Snapshot

Last accounts made up to 31 Dec 2024
Next accounts due 30 Sept 2026 (10 months)
Cash in Bank
£0.34m
↓ 23%
Turnover
£2.1m
↑ 15%
EBITDA
£0.45m
↑ 8%
Gross Profit
£0.89m
↑ 12%
Total Liabilities
£0.72m
↓ 17%
Employees
14
↑ 0%
Unlock financial data with Pro Start Free Trial →

People

Officers
12
Shareholders
202
Controllers (PSC)
0
Patrick Volkert Jozef Johannes Vink
Director • Dutch • Lives in Switzerland • Born in Jun 1963
Kaasim Mahmood
Director • British • Lives in England • Born in May 1976
Naveed Siddiqi
Director • British • Lives in England • Born in Jan 1967
Timothy Anderson
Director • American • Lives in United States • Born in Nov 1989
Francesco Maria Lavino
Director • Italian • Lives in United States • Born in Apr 1973

Registered Office Address

Lab B, Ground Floor Block 50 Alderley Park

Nether Alderley

Macclesfield

SK10 4TF

United Kingdom

Basic Information

LTD
10 Jun 1998
ENGLAND WALES
Yes

Industry Classification

72110

Company Attributes

N/A
N/A
N/A
N/A

Summary

44
Officers
0
PSCs
0
Filings